Safety of the extension of use of galacto‐oligosaccharides as a Novel food pursuant to Regulation (EU) 2015/2283
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the extension of use of galacto‐oligosaccharides (GOS) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is a syrup contain...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Wiley
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/b6c759fd8a744cfda2630cc7c4cb7b75 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:b6c759fd8a744cfda2630cc7c4cb7b75 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:b6c759fd8a744cfda2630cc7c4cb7b752021-11-23T08:30:51ZSafety of the extension of use of galacto‐oligosaccharides as a Novel food pursuant to Regulation (EU) 2015/22831831-473210.2903/j.efsa.2021.6844https://doaj.org/article/b6c759fd8a744cfda2630cc7c4cb7b752021-10-01T00:00:00Zhttps://doi.org/10.2903/j.efsa.2021.6844https://doaj.org/toc/1831-4732Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the extension of use of galacto‐oligosaccharides (GOS) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is a syrup containing ≥ 57% w/w GOS (w/w dry matter), consisting of different galactosyl residues linked to a terminal glucose by a β‐glycosidic bond and also containing lactose and the constituent monomers of lactose (galactose and glucose). The NF is already authorised and included in the Union list of NFs and is produced according to the same production process. This application is limited to an assessment of the extension of use as a food ingredient in dairy confectionary, cheese and processed cheese, butter and spreads. There is a 10–30% increase in total GOS intake from the requested extension of use compared to the currently authorised uses at the highest 95th percentile. It is noted that the total intake at the highest mean (8.7–22.0 g/day) is below the adequate intake (AI) of 25 g/day for dietary fibre set to ensure a normal laxation in adults, while the highest 95th percentile (27.2–41.6 g/day) is higher than the AI. When the maximum use as a food supplement is added to the highest 95th percentile combined intake from all proposed and authorised food categories a total intake up to 58 g GOS/day is estimated. This highest intake level would exceed the AI for dietary fibre; however, no tolerable upper intake level for dietary fibre has been set and only transient gastrointestinal symptoms may be related to high intake of fibre. The Panel concludes that the NF, that is composed of ≥ 57% GOS dry matter, lactose and related saccharides, is safe under the proposed extension of use.EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)Dominique TurckTorsten BohnJacqueline CastenmillerStefaan De HenauwKaren Ildico Hirsch‐ErnstAlexandre MaciukInge MangelsdorfHarry J McArdleAndroniki NaskaCarmen PelaezKristina PentievaAlfonso SianiFrank ThiesSophia TsabouriMarco VincetiFrancesco CubaddaThomas FrenzelMarina HeinonenRosangela MarchelliMonika Neuhäuser‐BertholdMorten PoulsenMiguel Prieto MaradonaJosef Rudolf SchlatterHenk van LoverenPaolo ColomboHelle Katrine KnutsenWileyarticleGalacto‐oligosaccharidesGOSdietary fibrenovel foodfood supplementextension of useNutrition. Foods and food supplyTX341-641Chemical technologyTP1-1185ENEFSA Journal, Vol 19, Iss 10, Pp n/a-n/a (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Galacto‐oligosaccharides GOS dietary fibre novel food food supplement extension of use Nutrition. Foods and food supply TX341-641 Chemical technology TP1-1185 |
| spellingShingle |
Galacto‐oligosaccharides GOS dietary fibre novel food food supplement extension of use Nutrition. Foods and food supply TX341-641 Chemical technology TP1-1185 EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) Dominique Turck Torsten Bohn Jacqueline Castenmiller Stefaan De Henauw Karen Ildico Hirsch‐Ernst Alexandre Maciuk Inge Mangelsdorf Harry J McArdle Androniki Naska Carmen Pelaez Kristina Pentieva Alfonso Siani Frank Thies Sophia Tsabouri Marco Vinceti Francesco Cubadda Thomas Frenzel Marina Heinonen Rosangela Marchelli Monika Neuhäuser‐Berthold Morten Poulsen Miguel Prieto Maradona Josef Rudolf Schlatter Henk van Loveren Paolo Colombo Helle Katrine Knutsen Safety of the extension of use of galacto‐oligosaccharides as a Novel food pursuant to Regulation (EU) 2015/2283 |
| description |
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the extension of use of galacto‐oligosaccharides (GOS) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is a syrup containing ≥ 57% w/w GOS (w/w dry matter), consisting of different galactosyl residues linked to a terminal glucose by a β‐glycosidic bond and also containing lactose and the constituent monomers of lactose (galactose and glucose). The NF is already authorised and included in the Union list of NFs and is produced according to the same production process. This application is limited to an assessment of the extension of use as a food ingredient in dairy confectionary, cheese and processed cheese, butter and spreads. There is a 10–30% increase in total GOS intake from the requested extension of use compared to the currently authorised uses at the highest 95th percentile. It is noted that the total intake at the highest mean (8.7–22.0 g/day) is below the adequate intake (AI) of 25 g/day for dietary fibre set to ensure a normal laxation in adults, while the highest 95th percentile (27.2–41.6 g/day) is higher than the AI. When the maximum use as a food supplement is added to the highest 95th percentile combined intake from all proposed and authorised food categories a total intake up to 58 g GOS/day is estimated. This highest intake level would exceed the AI for dietary fibre; however, no tolerable upper intake level for dietary fibre has been set and only transient gastrointestinal symptoms may be related to high intake of fibre. The Panel concludes that the NF, that is composed of ≥ 57% GOS dry matter, lactose and related saccharides, is safe under the proposed extension of use. |
| format |
article |
| author |
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) Dominique Turck Torsten Bohn Jacqueline Castenmiller Stefaan De Henauw Karen Ildico Hirsch‐Ernst Alexandre Maciuk Inge Mangelsdorf Harry J McArdle Androniki Naska Carmen Pelaez Kristina Pentieva Alfonso Siani Frank Thies Sophia Tsabouri Marco Vinceti Francesco Cubadda Thomas Frenzel Marina Heinonen Rosangela Marchelli Monika Neuhäuser‐Berthold Morten Poulsen Miguel Prieto Maradona Josef Rudolf Schlatter Henk van Loveren Paolo Colombo Helle Katrine Knutsen |
| author_facet |
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) Dominique Turck Torsten Bohn Jacqueline Castenmiller Stefaan De Henauw Karen Ildico Hirsch‐Ernst Alexandre Maciuk Inge Mangelsdorf Harry J McArdle Androniki Naska Carmen Pelaez Kristina Pentieva Alfonso Siani Frank Thies Sophia Tsabouri Marco Vinceti Francesco Cubadda Thomas Frenzel Marina Heinonen Rosangela Marchelli Monika Neuhäuser‐Berthold Morten Poulsen Miguel Prieto Maradona Josef Rudolf Schlatter Henk van Loveren Paolo Colombo Helle Katrine Knutsen |
| author_sort |
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) |
| title |
Safety of the extension of use of galacto‐oligosaccharides as a Novel food pursuant to Regulation (EU) 2015/2283 |
| title_short |
Safety of the extension of use of galacto‐oligosaccharides as a Novel food pursuant to Regulation (EU) 2015/2283 |
| title_full |
Safety of the extension of use of galacto‐oligosaccharides as a Novel food pursuant to Regulation (EU) 2015/2283 |
| title_fullStr |
Safety of the extension of use of galacto‐oligosaccharides as a Novel food pursuant to Regulation (EU) 2015/2283 |
| title_full_unstemmed |
Safety of the extension of use of galacto‐oligosaccharides as a Novel food pursuant to Regulation (EU) 2015/2283 |
| title_sort |
safety of the extension of use of galacto‐oligosaccharides as a novel food pursuant to regulation (eu) 2015/2283 |
| publisher |
Wiley |
| publishDate |
2021 |
| url |
https://doaj.org/article/b6c759fd8a744cfda2630cc7c4cb7b75 |
| work_keys_str_mv |
AT efsapanelonnutritionnovelfoodsandfoodallergensnda safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT dominiqueturck safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT torstenbohn safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT jacquelinecastenmiller safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT stefaandehenauw safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT karenildicohirschernst safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT alexandremaciuk safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT ingemangelsdorf safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT harryjmcardle safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT andronikinaska safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT carmenpelaez safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT kristinapentieva safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT alfonsosiani safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT frankthies safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT sophiatsabouri safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT marcovinceti safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT francescocubadda safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT thomasfrenzel safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT marinaheinonen safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT rosangelamarchelli safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT monikaneuhauserberthold safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT mortenpoulsen safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT miguelprietomaradona safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT josefrudolfschlatter safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT henkvanloveren safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT paolocolombo safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 AT hellekatrineknutsen safetyoftheextensionofuseofgalactooligosaccharidesasanovelfoodpursuanttoregulationeu20152283 |
| _version_ |
1718416846291468288 |